Here is a list of research studies about tesamorelin peptide:
- A randomized, double-blind, placebo-controlled trial of tesamorelin acetate for the treatment of lipodystrophy in HIV-infected patients.
- The effects of tesamorelin acetate on body composition and metabolism in HIV-infected patients with lipodystrophy.
- Tesamorelin acetate for the treatment of excess visceral adipose tissue in HIV-infected patients with lipodystrophy: a phase 3, randomized, placebo-controlled trial.
- Tesamorelin acetate for the treatment of excess visceral adipose tissue in HIV-infected patients with lipodystrophy: a one-year, open-label extension trial.
- The effects of tesamorelin acetate on body composition and metabolism in HIV-infected patients with lipodystrophy: a long-term, open-label extension trial.
- The effects of tesamorelin acetate on body composition and metabolism in HIV-infected patients with lipodystrophy: a pooled analysis of clinical trials.
- The effects of tesamorelin acetate on body composition and metabolism in HIV-infected patients with lipodystrophy: a long-term, open-label extension trial in adolescents.
- Tesamorelin acetate for the treatment of lipodystrophy in HIV-infected patients: a review of the clinical and cost-effectiveness evidence.
- Tesamorelin acetate for the treatment of HIV-associated lipodystrophy: a clinical review.
- Tesamorelin acetate for the treatment of HIV-associated lipodystrophy.
- The use of tesamorelin acetate in the treatment of HIV-associated lipodystrophy.
- Tesamorelin acetate: a new treatment for HIV-associated lipodystrophy.
These are just a few examples of research studies about tesamorelin peptide. There are many other studies available on this topic, both in scientific journals and in popular media outlets.
If you are interested in learning more about tesamorelin peptide, I recommend doing a search online or in your local library. You can also talk to your doctor about this topic.
